Baxter Issues Voluntary Nationwide Recall For One Lot Of Anticoagulant Sodium Citrate Solution Due To Potential Presence Of Particulate Matter

Recalling firm

Baxter

Product

for One Lot of Anticoagulant Sodium Citrate Solution

Reason

FOR IMMEDIATE RELEASE – AUG. 25, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling one lot of Anticoagulant Sodium Citrate Solution due to the potential presence of particulate matter identified as fiberglass in the solution.

Category

drug recall

Country

United States

Agency

FDA-MEDWATCH-RSS

Recall date

2026-08-25

Status

Ongoing

Official recall notice from FDA-MEDWATCH-RSS

Recall details on Nibble Recalls: https://trynibble.app/recalls/5cb65933-1066-4d50-b8de-bd89e6ae048c